ROSEVILLE, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- InnerScope Hearing Technologies Inc. (OTCQB: INND) ("InnerScope") a manufacturer and Direct-to-Consumer distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products, ("Hearing Products") Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CDB Oil for Tinnitus ("Hearing Health Products"), announced today it was recognized and named as the 2019 Biotechnology Awards winner for the Best Hearing Aid Manufacturer in the USA and for its Innovation in the Direct-to-Consumer ("DTC") Hearing Aid Delivery Process by Global Health & Pharma magazine ("GHP"). InnerScope was nominated and recognized globally for its life-changing innovations and developments for helping the 1.2 billion people worldwide that suffer from hearing loss. These prestigious global awards was given to InnerScope by GHP, a global information-sharing platform of Human, Animal, Environmental Health & Pharmaceutical news with readership of over 260,000 wellness professionals and healthcare-related suppliers worldwide.
InnerScope's award winning DTC Hearing Aid Delivery Process allows the hearing impaired individual to have easy access to latest in high-quality affordable hearing aids at factory-direct pricing without leaving the comfort of their home. Additionally, through a process of review, interview and research by GHP, InnerScope, was also recognized for its tireless work and dedication in helping to change millions of peoples lives with its continued advancements in Hearing Products and related Hearing Treatment Therapies.
Under GHP's microscope for the 2019 Biotechnology Awards were a variety of verticals, including bio agriculture, bio services, bio industrial and biopharmaceutical, the biotechnology market. These endeavors in biotechnology, boasting impressive market value growth with no signs of slowing in making advancements in laboratories as well as in boardrooms that help lives globally is GHP award platform. The GHP awards are given solely on merit through contributions made by the organizations and individuals operating within the world's most vital industries.
Steve Simpson, Awards Coordinator commented on the awards and their deserving winners: "Through this awards programme, GHP honours a range of companies active within the sector. It is with great pride that I congratulate InnerScope Hearing Technologies for its hard work across the hearing aid development space and wish the team the best of luck for the future." To find out more InnerScope's story and other 2019 award recipients, click on the link 2019 Biotechnology Awards recipient supplement
"InnerScope and its team of dedicated and highly skilled professionals are very humble and proud to have been recognized globally for developing industry break-through achievements for helping the tens of millions of people to hear better," said Matthew Moore, CEO InnerScope Hearing Technology.
"This is only the beginning of many hearing industry-breakthroughs that InnerScope will achieve. Looking ahead, InnerScope plans to play a major role in reshaping the hearing aid industry through its disruptive innovation, by creating a better more affordable and efficient way to deliver better hearing health to the 1.2 billion people worldwide. InnerScope has already taken the role as the lead disruptor with its long-term vendor wholesale agreement with Walmart.com, by giving easy online access to purchase its' patented high quality DTC hearing aids at factory direct prices to millions of Walmart.com customers. However, we believe the "NEXUS", InnerScope's newest development of a line of "Self-Fitting" Hearing Aids, expected to launch next month on Walmart.com, will have even a greater disruptive impact on the current $10 billion dollar hearing aid market by overtaking the traditional professional-fitted hearing aids. InnerScope is also leading the way in developing new innovative Hearing Health Products, which includes treating multiple hearing disorders using Low-Level Laser Technology (currently conducting a FDA-510k clinical trial of treatment of Tinnitus) as well its' proprietary CDB Oil also for Tinnitus along with its line of Doctor-Formulated Dietary Hearing Supplements "Nutrition for the Ears" for overall better health and well-being," Mr. Moore, concluded.
About InnerScope Hearing Technologies ("INND")
InnerScope Hearing Technologies (OTCQB: INND) is a rapidly expanding consolidator of the hearing aid industry. Management is applying decades of profitable industry experience and technology to an antiquated and disjointed industry, unlocking scale and efficiency, which will serve all of InnerScope's stakeholders. Its direct-to-consumer model is revolutionizing the industry with its Walmart.com relationship representing a paramount shift in the consumption of hearing aids by the hearing impaired.
In addition, InnerScope plans to continue to open, acquire, and operate a physical chain of audiological and retail hearing device clinics. InnerScope's mission is to serve approximately 1.2 billion people around the globe that are suffering with 25 db or greater hearing loss across the entire hearing impaired vertical from R&D and manufacturing through direct consumer sales and services. For more information, please visit: www.innd.com For the Most Up-to-Date information about InnerScope Hearing Technologies (OTCQB: INND), please visit and follow our Official Twitter account @inndstock Page. https://twitter.com/inndstock
About GHP Magazine
Global Health and Pharma magazine located in the United Kingdom, is a global information sharing platform & a multi-disciplinary member's community. The publication was established to enhance communication networks & collaboration across all themes and disciplines within three main categories; Human, Animal & Environmental Health. To find out more please visit http://www.ghp-news.com/
Safe Harbor
This presentation contains forward-looking statements, which relate to future events or InnerScope Hearing Technologies future performance or financial condition. Any statements that are not statements of historical fact (including statements containing the words "believes," "should," "plans," "anticipates," "expects," "estimates" and similar expressions) should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in InnerScope Hearing Technologies filings with the Securities and Exchange Commission. InnerScope Hearing Technologies undertakes no duty to update any forward-looking statements made herein.
Contact
InnerScope Hearing Technologies, Inc.
Investor Relations
Info@innd.com
916-218-4100
www.innd.com
2019 Biotechnology Awards recipient supplement
For the Most Up-to-Date information about InnerScope Hearing Technologies (OTCQB: INND), please visit and follow our Official Twitter account @inndstock Page. https://twitter.com/inndstock